Paying users zone. Data is hidden behind: .
Get 1-month access to Bristol-Myers Squibb Co. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Bristol-Myers Squibb Co. pages available today for free:
Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Bristol-Myers Squibb Co., common-size consolidated balance sheet: liabilities and stockholders’ equity
|Balance sheet item||Description||The company|
|Current liabilities||Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.||Bristol-Myers Squibb Co.’s current liabilities as a percentage of total liabilities and equity increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.|
|Non-current liabilities||Amount of obligation due after one year or beyond the normal operating cycle, if longer.||Bristol-Myers Squibb Co.’s non-current liabilities as a percentage of total liabilities and equity decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.|
|Total liabilities||Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.||Bristol-Myers Squibb Co.’s total liabilities as a percentage of total liabilities and equity decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.|
|Total Bristol-Myers Squibb Company shareholders’ equity||Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.||Bristol-Myers Squibb Co.’s total Bristol-Myers Squibb Company shareholders’ equity as a percentage of total liabilities and equity increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.|